.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Daiichi Sankyo
Moodys
UBS
Cipla
Baxter
Fuji
Medtronic
Covington

Generated: September 26, 2017

DrugPatentWatch Database Preview

Escitalopram oxalate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for escitalopram oxalate and what is the scope of escitalopram oxalate freedom to operate?

Escitalopram oxalate
is the generic ingredient in two branded drugs marketed by Invagen Pharms, Macleods Pharms Ltd, Sti Pharma Llc, Amneal Pharms, Hetero Labs Ltd Iii, Taro, Forest Labs, Aurobindo Pharma Ltd, Prinston Inc, Zydus Pharms Usa Inc, Torrent Pharms Ltd, Mylan Pharms Inc, Teva Pharms Usa, Hikma Pharms, Antrim Pharms Llc, Lupin Ltd, Silarx Pharms Inc, Apotex Inc, Jubilant Generics, and Accord Hlthcare, and is included in twenty-five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for escitalopram oxalate. Fifty-nine suppliers are listed for this compound. There are six tentative approvals for this compound.

Summary for Generic Name: escitalopram oxalate

Tradenames:2
Patents:2
Applicants:20
NDAs:25
Drug Master File Entries: see list25
Suppliers / Packagers: see list59
Bulk Api Vendors: see list68
Clinical Trials: see list320
Patent Applications: see list640
Therapeutic Class:Anxiolytics
Drug Prices:see low prices
DailyMed Link:escitalopram oxalate at DailyMed

Pharmacology for Ingredient: escitalopram oxalate

Tentative approvals for ESCITALOPRAM OXALATE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe5MGTABLET; ORAL
► Subscribe► Subscribe20MGTABLET; ORAL
► Subscribe► Subscribe10MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL202210-003Sep 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ESCITALOPRAM OXALATE
escitalopram oxalate
SOLUTION;ORAL079062-001Apr 2, 2012AARXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL076765-003Mar 14, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL078169-003Sep 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL078766-003Sep 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Forest Labs
LEXAPRO
escitalopram oxalate
TABLET;ORAL021323-002Aug 14, 2002ABRXYesNo► Subscribe► SubscribeY► Subscribe
Forest Labs
LEXAPRO
escitalopram oxalate
SOLUTION;ORAL021365-001Nov 27, 2002AARXYesYes► Subscribe► Subscribe► Subscribe
Amneal Pharms
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL205619-003May 17, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL077734-002Sep 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ESCITALOPRAM OXALATE
escitalopram oxalate
CAPSULE;ORAL077660-001Jul 31, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: escitalopram oxalate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs
LEXAPRO
escitalopram oxalate
TABLET;ORAL021323-001Aug 14, 2002► Subscribe► Subscribe
Forest Labs
LEXAPRO
escitalopram oxalate
SOLUTION;ORAL021365-001Nov 27, 2002► Subscribe► Subscribe
Forest Labs
LEXAPRO
escitalopram oxalate
TABLET;ORAL021323-002Aug 14, 2002► Subscribe► Subscribe
Forest Labs
LEXAPRO
escitalopram oxalate
TABLET;ORAL021323-003Aug 14, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Merck
Healthtrust
Citi
Queensland Health
US Army
Chinese Patent Office
Baxter
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot